Spinocerebellar Ataxia tests in Dubai & UAE

Compare available Spinocerebellar Ataxia tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,200.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Spinocerebellar Ataxia test prices

Showing 1–14 of 14 matching tests.

Spinocerebellar Ataxia diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5848 ANO10 Gene Spinocerebellar Ataxia Type 10, Autosomal Recessive Genetic Test This test evaluates the ANO10 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 10 (SCAR10). It identifies mutations responsible for the...	Whole Blood, Extracted DNA, or One Drop of Blood on an FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ANO10 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed before the test"] Indications ["Individuals with clinical features suggestive of spinocerebellar ataxia type 10", "Family history of SCAR10", "Carrier screening in families with known SCAR10 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21657-1 ICD-10: G11.2 Clinical summary This test evaluates the ANO10 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 10 (SCAR10). It identifies mutations responsible for the neurological disorder.
TEST-5844 ATP2B3 Gene Spinocerebellar Ataxia Type 1 (X‑Linked) Genetic Test This genetic test evaluates the ATP2B3 gene for mutations associated with X-linked spinocerebellar ataxia type 1.	Peripheral whole blood (EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP2B3 gene sequence", "Copy Number Variations (CNV) in ATP2B3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Clinical suspicion of X-linked spinocerebellar ataxia type 1", "Family history of X-linked ataxia", "Carrier testing for female relatives", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21643-9 ICD-10: G11.8, Z14.8, Z82.79 Clinical summary This genetic test evaluates the ATP2B3 gene for mutations associated with X-linked spinocerebellar ataxia type 1.
TEST-5737 ATXN1 Gene Spinocerebellar Ataxia Type 1 (SCA1) Autosomal Dominant Genetic Test This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN1 gene, confirming a diagnosis of Autosomal Dominant Spinocerebellar Ataxia Type 1 (SCA1).	Peripheral Whole Blood (5 mL)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATXN1 gene"] Parameters [] Preparation ["Inform phlebotomist about anticoagulant therapy"] Indications ["Diagnosis of suspected SCA1", "Predictive testing for at-risk family members", "Prognostic evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 94880-2 ICD-10: G11.0 Clinical summary This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN1 gene, confirming a diagnosis of Autosomal Dominant Spinocerebellar Ataxia Type 1 (SCA1).
TEST-5778 FGF14 Gene Spinocerebellar Ataxia Type 27 (Autosomal Dominant) Genetic Test This genetic test evaluates the FGF14 gene for pathogenic variants associated with autosomal dominant spinocerebellar ataxia type 27 (SCA27).	Peripheral Blood	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGF14 gene", "Presence of mutations causing SCA27"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Suspected diagnosis of SCA27", "Family history of SCA27", "Neurological symptoms consistent with SCA27"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.8 Clinical summary This genetic test evaluates the FGF14 gene for pathogenic variants associated with autosomal dominant spinocerebellar ataxia type 27 (SCA27).
TEST-5754 GRM1 Gene Spinocerebellar Ataxia Type 13, Autosomal Recessive Genetic Test This test identifies pathogenic variants in the GRM1 gene associated with autosomal recessive Spinocerebellar Ataxia Type 13.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in GRM1 gene coding exons and splice sites"] Parameters [] Preparation ["No fasting required", "No medication adjustment required"] Indications ["Suspected diagnosis of Spinocerebellar Ataxia Type 13", "Family history of autosomal recessive ataxia", "Genetic counselling for ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 21615-1 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants in the GRM1 gene associated with autosomal recessive Spinocerebellar Ataxia Type 13.
TEST-5867 IFRD1 Gene Spinocerebellar Ataxia Type 18 (Autosomal Dominant) Genetic Test This test identifies pathogenic variants in the IFRD1 gene associated with autosomal dominant spinocerebellar ataxia type 18.	Peripheral whole blood (3 mL EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IFRD1 gene coding exons", "IFRD1 gene intron–exon boundaries"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Diagnosis of suspected Spinocerebellar Ataxia Type 18 (SCA18)", "Family risk assessment for SCA18", "Prognostic counselling for SCA18"] Measurement technique Confirm with laboratory Codes LOINC: 81325-1 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the IFRD1 gene associated with autosomal dominant spinocerebellar ataxia type 18.
TEST-5855 KCNC3 Gene Spinocerebellar Ataxia Type 13 (Autosomal Dominant) Genetic Test This test analyzes the KCNC3 gene to identify pathogenic variants associated with Spinocerebellar Ataxia Type 13 (SCA13). It confirms the genetic basis for this specific type of in...	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNC3 gene", "Exons and flanking intronic regions of KCNC3"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% (SNVs, small indels)"}, {"name": "Variant Detection", "reference_range": "Full gene coverage (exons ±15 bp flanking introns)"}] Preparation ["Informed consent form must be signed prior to sample collection.", "Inform the geneticist about any ongoing treatments."] Indications ["Diagnosis of suspected SCA13", "Familial risk assessment for SCA13", "Predictive testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.8 Clinical summary This test analyzes the KCNC3 gene to identify pathogenic variants associated with Spinocerebellar Ataxia Type 13 (SCA13). It confirms the genetic basis for this specific type of inherited ataxia.
TEST-5876 KCND3 Gene Spinocerebellar Ataxia Type 22 (Autosomal Dominant) Genetic Test This test identifies mutations in the KCND3 gene associated with autosomal dominant Spinocerebellar Ataxia Type 22 (SCA22).	Whole Blood (EDTA) • Extracted DNA • Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCND3 gene sequence", "Pathogenic variants in KCND3"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of Spinocerebellar Ataxia Type 22", "Family history of SCA22", "Need for definitive diagnosis", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 101061-1 ICD-10: G11.8, Z82.0, Z14.8 Clinical summary This test identifies mutations in the KCND3 gene associated with autosomal dominant Spinocerebellar Ataxia Type 22 (SCA22).
TEST-5793 NOP56 Gene Spinocerebellar Ataxia Type 36 (SCA36) Autosomal Dominant Genetic Test This test detects pathogenic GGCCTG hexanucleotide repeat expansions in the NOP56 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 36 (SCA36).	Peripheral whole blood (EDTA tube)	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GGCCTG hexanucleotide repeat expansion", "Pathogenic repeat length"] Parameters [] Preparation [] Indications ["Suspected SCA36 based on clinical presentation", "Family history of SCA36", "Genetic counselling for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 81317-5 ICD-10: G11.2 Clinical summary This test detects pathogenic GGCCTG hexanucleotide repeat expansions in the NOP56 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 36 (SCA36).
TEST-5891 PLEKHG4 Genetic SCA4 Test This test identifies pathogenic variants in the PLEKHG4 gene associated with Spinocerebellar Ataxia Type 4 (SCA4). It provides definitive molecular confirmation for individuals sus...	Whole Blood (Peripheral), Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PLEKHG4 gene", "Presence of mutations causing SCA4"] Parameters [] Preparation ["No fasting required", "Ensure hydration", "Inform phlebotomist of anticoagulant medications"] Indications ["Patients with clinical suspicion of SCA4", "Family history of SCA4", "Predictive testing in asymptomatic individuals with known family variant (after genetic counseling)"] Measurement technique Confirm with laboratory Codes LOINC: 21684-4 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the PLEKHG4 gene associated with Spinocerebellar Ataxia Type 4 (SCA4). It provides definitive molecular confirmation for individuals suspected of having this condition.
TEST-5859 PRKCG Gene Spinocerebellar Ataxia Type 14 (Autosomal Dominant) Test This genetic test identifies pathogenic variants in the PRKCG gene associated with autosomal dominant Spinocerebellar Ataxia Type 14 (SCA14).	Whole Blood, Extracted DNA, or FTA Card (One Drop Blood)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKCG gene"] Parameters [] Preparation [] Indications ["Diagnosis of SCA14", "Family risk assessment for SCA14", "Prognosis determination for SCA14"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: G11.8, Z14.8, R27.0 Clinical summary This genetic test identifies pathogenic variants in the PRKCG gene associated with autosomal dominant Spinocerebellar Ataxia Type 14 (SCA14).
TEST-3065 SCA‑14 (PRKCG Gene Mutation) Test This test identifies pathogenic variants in the PRKCG gene associated with autosomal dominant spinocerebellar ataxia type 14.	Whole Blood (EDTA)	10-12 Business Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKCG gene"] Parameters [] Preparation ["Provide a duly filled Genomic Information Form (Form 20)", "Provide 4 mL whole blood in an EDTA tube"] Indications ["Diagnosis of suspected SCA‑14", "Genetic counseling for families with SCA‑14"] Measurement technique Confirm with laboratory Codes LOINC: 98590-0 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants in the PRKCG gene associated with autosomal dominant spinocerebellar ataxia type 14.
TEST-3061 SCA11 (Spinocerebellar Ataxia Type 11) Test This test identifies pathogenic variants in the TTBK2 gene associated with Spinocerebellar Ataxia Type 11 (SCA11). It provides definitive genotypic evidence for diagnosing this spe...	EDTA Whole Blood (Peripheral)	10–12 business days from specimen receipt	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TTBK2 gene", "Coding region and intron-exon boundaries of TTBK2"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of suspected SCA11", "Predictive testing for at-risk relatives", "Family counselling"] Measurement technique Confirm with laboratory Codes LOINC: 93969-6 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the TTBK2 gene associated with Spinocerebellar Ataxia Type 11 (SCA11). It provides definitive genotypic evidence for diagnosing this specific type of hereditary ataxia.
TEST-5798 SPTBN2 Gene Sequencing (Spinocerebellar Ataxia Type 5, Autosomal Dominant) Test This test identifies pathogenic variants in the SPTBN2 gene to diagnose autosomal dominant spinocerebellar ataxia type 5 (SCA5).	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPTBN2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected hereditary ataxia", "Family history of SCA5", "Need for definitive diagnosis of SCA5"] Measurement technique Confirm with laboratory Codes LOINC: 94547-4 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants in the SPTBN2 gene to diagnose autosomal dominant spinocerebellar ataxia type 5 (SCA5).

Category overview

Spinocerebellar Ataxia: overview

Confronting progressive loss of coordination, balance issues, or a family history of movement disorders can be deeply unsettling, but precise genetic factors provide a clear path forward. Within our advanced neurogenetics department, Spinocerebellar Ataxia (SCA) testing meticulously evaluates your DNA for the specific trinucleotide repeats or mutations causing this progressive neurological condition. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening clarifies the hereditary nature of your symptoms, safely guiding personalized neurological care, physical therapy, and proactive family planning. Recognized for neurogenetic excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional diagnostic accuracy, and rapid reporting. Take an informed step in your neurological health—schedule your spinocerebellar ataxia testing in UAE, book a secure home sample collection, or consult our expert neurology genetics specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.